FDA Approves NUCYNTA ER Extended Release Oral Tablets
Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA ER is the first and only opioid approved by the FDA for this purpose. “Pain from DPN can be difficult to manage, leaving some patients …
FDA Approves NUCYNTA ER Extended Release Oral Tablets Read More »